Live

3rd Annual Symposium on Individualized Novel Disease-Modifying Treatment Options for Multiple Sclerosis September 10, 2016 Houston, TX

Biological Therapies for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Osteoarthritis: Comparative Effectiveness Based on Treatment Profiles and Guideline Recommendations September 19, 2015 Philadelphia, PA

2nd Annual Symposium on Current Strategies in the Diagnosis and Treatment of Multiple Sclerosis  April 11, 2015 Dallas, TX

View All Live Programs

New Webcasts

New Paradigms in the Prevention and Treatment of Migraine with HT1F Agonist and mAb Against CGRP Pathway or its Receptor Released on 11/25/19 Expires on 11/25/20

New Horizons in Reducing Cardiovascular Disease Risk in Patients with Type 2 Diabetes with SGLT-2, GLP-1 RAs and DPP-4 Based Therapies Released on 6/14/19 Expires on 6/14/20

Changing Landscape of GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction and Cardiovascular Outcomes in Individuals with Diabetes Released on 6/12/19 Expires on 6/12/20

Changing Landscape of Treatment Options for Migraine with Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) Pathway or its Receptor Released on 3/22/19 Expires on 3/22/20

Emerging Newer Therapies in the Management of Lung Function, Exacerbations, Safety and Tolerability in Patients with COPD Released on 8/9/18 Expires on 8/9/19

Emerging Anti-Interleukin 5 (IL-5) and IL-5Ra Based Biological Therapies: Efficacy, Safety and Future Perspectives in Severe Eosinophilic Asthma Released on 7/12/18 Expires on 7/12/19

Emerging Interleukin-5 (IL-5) or its Receptor (IL-5R) Monoclonal Antibody Based Biological Therapies for Severe or Poorly Controlled Asthma Released on 6/29/18 Expires on  6/29/19

Emerging Strategies in the Diagnosis and Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Released on 6/19/18 Expires on 6/19/19